Sinopharm Group Ltd Stock Analysis
| SHTDY Stock | USD 11.99 0.02 0.17% |
SINOPHARM GROUP LTD is fairly valued with Real Value of 11.73 and Hype Value of 11.99. The main objective of SINOPHARM GROUP pink sheet analysis is to determine its intrinsic value, which is an estimate of what SINOPHARM GROUP LTD is worth, separate from its market price. There are two main types of SINOPHARM GROUP's stock analysis: fundamental analysis and technical analysis.
The SINOPHARM GROUP pink sheet is traded in the USA on PINK Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA.
SINOPHARM |
SINOPHARM Pink Sheet Analysis Notes
The company has price-to-book ratio of 0.9. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. SINOPHARM GROUP LTD last dividend was issued on the 24th of June 2022. Ltd., together with its subsidiaries, engages in the wholesale and retail of pharmaceutical and medical devices and healthcare products in the Peoples Republic of China. Ltd. is a subsidiary of Sinopharm Industrial Investment Co., Ltd. Sinopharm is traded on OTC Exchange in the United States.The quote for SINOPHARM GROUP LTD is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To find out more about SINOPHARM GROUP LTD contact the company at 86 21 2305 2666 or learn more at https://www.sinopharmgroup.com.cn.SINOPHARM Market Capitalization
The company currently falls under 'Mid-Cap' category with a current market capitalization of 8.61 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate SINOPHARM GROUP's market, we take the total number of its shares issued and multiply it by SINOPHARM GROUP's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.SINOPHARM Profitablity
The company has Profit Margin (PM) of 0.01 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.04 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.04.Technical Drivers
As of the 21st of July, SINOPHARM GROUP has the coefficient of variation of 1081.04, and Risk Adjusted Performance of 0.0895. In connection with fundamental indicators, the technical analysis model makes it possible for you to check practical technical drivers of SINOPHARM GROUP LTD, as well as the relationship between them.SINOPHARM GROUP LTD Price Movement Analysis
The output start index for this execution was twenty-nine with a total number of output elements of thirty-two. The Simple Moving Average indicator is calculated by adding the closing price of SINOPHARM GROUP for a given number of time periods and then dividing this total by the number of time periods. It is used to smooth out SINOPHARM GROUP LTD short-term fluctuations and highlight longer-term trends or cycles.
SINOPHARM GROUP Outstanding Bonds
SINOPHARM GROUP issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. SINOPHARM GROUP LTD uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most SINOPHARM bonds can be classified according to their maturity, which is the date when SINOPHARM GROUP LTD has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View |
SINOPHARM GROUP Predictive Daily Indicators
SINOPHARM GROUP intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of SINOPHARM GROUP pink sheet daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
SINOPHARM GROUP Forecast Models
SINOPHARM GROUP's time-series forecasting models are one of many SINOPHARM GROUP's pink sheet analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary SINOPHARM GROUP's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About SINOPHARM Pink Sheet Analysis
Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how SINOPHARM GROUP prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling SINOPHARM shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as SINOPHARM GROUP. By using and applying SINOPHARM Pink Sheet analysis, traders can create a robust methodology for identifying SINOPHARM entry and exit points for their positions.
Ltd., together with its subsidiaries, engages in the wholesale and retail of pharmaceutical and medical devices and healthcare products in the Peoples Republic of China. Ltd. is a subsidiary of Sinopharm Industrial Investment Co., Ltd. Sinopharm is traded on OTC Exchange in the United States.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our pink sheet analysis tools, you can find out how much better you can do when adding SINOPHARM GROUP to your portfolios without increasing risk or reducing expected return.Did you try this?
Run ETFs Now
ETFsFind actively traded Exchange Traded Funds (ETF) from around the world |
| All Next | Launch Module |
Additional Tools for SINOPHARM Pink Sheet Analysis
When running SINOPHARM GROUP's price analysis, check to measure SINOPHARM GROUP's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy SINOPHARM GROUP is operating at the current time. Most of SINOPHARM GROUP's value examination focuses on studying past and present price action to predict the probability of SINOPHARM GROUP's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move SINOPHARM GROUP's price. Additionally, you may evaluate how the addition of SINOPHARM GROUP to your portfolios can decrease your overall portfolio volatility.